Ken Griffin’s Alpine Immune Sciences Inc ALPN Stock Holding History

Ken Griffin’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-142,879	Closed	-$5.66M	–	15793
2024 Q1	$5.66M	Sell	142,879 -732,378	-84%	-$21.6M	﹤0.01%	3756
2023 Q4	$16.7M	Buy	875,257 +847,083	+3,007%	+$11.8M	﹤0.01%	2206
2023 Q3	$323K	Sell	28,174 -25,549	-48%	-$314K	﹤0.01%	9029
2023 Q2	$552K	Buy	+53,723	New	+$484K	﹤0.01%	7728
2023 Q1	–	Sell	-21,204	Closed	-$156K	–	15765
2022 Q4	$156K	Buy	+21,204	New	+$136K	﹤0.01%	10557
2021 Q2	–	Sell	-22,030	Closed	-$234K	–	14629
2021 Q1	$234K	Buy	+22,030	New	+$275K	﹤0.01%	11400
2016 Q1	–	Sell	-5,690	Closed	-$176K	–	8212
2015 Q4	$176K	Buy	+5,690	New	+$194K	﹤0.01%	5969

Ken Griffin's ALPN Position: Q2 2024 in Review

Ken Griffin sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 142,879 shares — an estimated $5.66M sold.

Ken Griffin first reported a position in ALPN in Q4 2015 and held it in 7 quarters. The position peaked at $16.7M in Q4 2023. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Ken Griffin reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Ken Griffin sold 142,879 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $5.66M.
Ken Griffin first reported a position in Alpine Immune Sciences Inc in Q4 2015 and held it in 7 quarters.
Ken Griffin's Alpine Immune Sciences Inc position peaked at $16.7M in Q4 2023.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.